- US indices finished yesterday's trading lower. S&P 500 dropped 0.86% while Dow Jones lost 0.75%. Nasdaq declined 0.72%. Russell 2000 finished trading 1.34% lower
- Pessimism dominated during the Asian trading hours. Nikkei dropped 1.5%, S&P/ASX200 moved 1.39% lower while Kospi declined 1.69%. Indices from China traded lower
- DAX futures point to a higher opening of the European session
- US reportedly added more Chinese firms to economic blacklist re human rights violations
- China inflation figures for June. CPI 1.1% y/y (expected 1.3%), PPI 8.8% y/y (expected 8.8%)
- South Korea reported record number of 1,316 new Covid-19 infections
- Australia's government has announced that due to rising number of cases approximately one million doses a week of the Pfizer vaccine will be provided
- BNZ analysts (which is one of New Zealand's big four banks) are expecting the QE program in New Zealand will end soon
- Another tapering from the BoC coming up next week according to all 21 analysts surveyed by Reuters
- COMEX copper, silver margins lowered
- Oil is trading higher while precious metals decline slightly
- Bitcoin trades above $ 33,000 mark
- CHF and JPY are the best performing major currencies while NZD and AUD lag the most
USDJPY started today’s session with an upward move following yesterday’s plunge. The price is currently testing the earlier broken support at 110.00. If sellers manage to defend this level again, the support at 107.50 should be considered the first target for bears. On the other hand, should buyers manage to bring price back above 110.00 level, then another upward impulse towards 111.00 could be launched. Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
